TheProfitWatch

PALI - Palisade Bio, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.89 -0.14 (-7.41%) --- --- 0.01 (0.59%) -0.04 (-2.12%) -0.1 (-5.72%) 0.02 (1.16%) 0.02 (1.16%)

Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.58
Diluted EPS:
-0.58
Basic P/E:
-3.0172
Diluted P/E:
-3.0172
RSI(14) 1m:
100.0
VWAP:
1.75
RVol:

Events

Period Kind Movement Occurred At

Related News